110 related articles for article (PubMed ID: 7646526)
1. Characterization of gene regulatory elements for selective gene expression in human melanoma cells.
Artuc M; Nürnberg W; Czarnetzki BM; Schadendorf D
Biochem Biophys Res Commun; 1995 Aug; 213(2):699-705. PubMed ID: 7646526
[TBL] [Abstract][Full Text] [Related]
2. Melanoma-specific expression in first-generation adenoviral vectors in vitro and in vivo -- use of the human tyrosinase promoter with human enhancers.
Lillehammer T; Tveito S; Engesaeter BO; Fodstad O; Maelandsmo GM; Engebraaten O
Cancer Gene Ther; 2005 Nov; 12(11):864-72. PubMed ID: 15891771
[TBL] [Abstract][Full Text] [Related]
3. Short and highly efficient synthetic promoters for melanoma-specific gene expression.
Martinelli R; De Simone V
FEBS Lett; 2005 Jan; 579(1):153-6. PubMed ID: 15620705
[TBL] [Abstract][Full Text] [Related]
4. Cotransfection of genes encoding human tyrosinase and tyrosinase-related protein-1 prevents melanocyte death and enhances melanin pigmentation and gene expression of Lamp-1.
Luo D; Chen H; Jimbow K
Exp Cell Res; 1994 Jul; 213(1):231-41. PubMed ID: 8020595
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional targeting of recombinant adenoviruses to human and murine melanoma cells.
Siders WM; Halloran PJ; Fenton RG
Cancer Res; 1996 Dec; 56(24):5638-46. PubMed ID: 8971169
[TBL] [Abstract][Full Text] [Related]
6. MIA (melanoma inhibitory activity) promoter mediated tissue-specific suicide gene therapy of malignant melanoma.
Schoensiegel F; Paschen A; Sieger S; Eskerski H; Mier W; Rothfels H; Kleinschmidt J; Schadendorf D; Haberkorn U
Cancer Gene Ther; 2004 Jun; 11(6):408-18. PubMed ID: 15118759
[TBL] [Abstract][Full Text] [Related]
7. Melanoma-specific cytotoxicity induced by a tyrosinase promoter-enhancer/herpes simplex virus thymidine kinase adenovirus.
Siders WM; Halloran PJ; Fenton RG
Cancer Gene Ther; 1998; 5(5):281-91. PubMed ID: 9824047
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo targeting of gene expression to melanoma cells.
Vile RG; Hart IR
Cancer Res; 1993 Mar; 53(5):962-7. PubMed ID: 8439971
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor alpha-mediated inhibition of melanogenesis is dependent on nuclear factor kappa B activation.
Englaro W; Bahadoran P; Bertolotto C; Buscà R; Dérijard B; Livolsi A; Peyron JF; Ortonne JP; Ballotti R
Oncogene; 1999 Feb; 18(8):1553-9. PubMed ID: 10102625
[TBL] [Abstract][Full Text] [Related]
10. A transcriptional feedback loop for tissue-specific expression of highly cytotoxic genes which incorporates an immunostimulatory component.
Emiliusen L; Gough M; Bateman A; Ahmed A; Voellmy R; Chester J; Diaz RM; Harrington K; Vile R
Gene Ther; 2001 Jul; 8(13):987-98. PubMed ID: 11438833
[TBL] [Abstract][Full Text] [Related]
11. Novel oncolytic adenoviruses targeted to melanoma: specific viral replication and cytolysis by expression of E1A mutants from the tyrosinase enhancer/promoter.
Nettelbeck DM; Rivera AA; Balagué C; Alemany R; Curiel DT
Cancer Res; 2002 Aug; 62(16):4663-70. PubMed ID: 12183423
[TBL] [Abstract][Full Text] [Related]
12. Tyrosinase-related proteins suppress tyrosinase-mediated cell death of melanocytes and melanoma cells.
Rad HH; Yamashita T; Jin HY; Hirosaki K; Wakamatsu K; Ito S; Jimbow K
Exp Cell Res; 2004 Aug; 298(2):317-28. PubMed ID: 15265682
[TBL] [Abstract][Full Text] [Related]
13. Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer.
Coulson JM; Stanley J; Woll PJ
Br J Cancer; 1999 Aug; 80(12):1935-44. PubMed ID: 10471042
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor p53 down-regulates tissue-specific expression of tyrosinase gene in human melanoma cell lines.
Kichina J; Green A; Rauth S
Pigment Cell Res; 1996 Apr; 9(2):85-91. PubMed ID: 8857671
[TBL] [Abstract][Full Text] [Related]
15. Correlation between the number of melanosomes, tyrosinase mRNA levels, and tyrosinase activity in cultured murine melanoma cells in response to various melanogenesis regulatory agents.
Ando H; Itoh A; Mishima Y; Ichihashi M
J Cell Physiol; 1995 Jun; 163(3):608-14. PubMed ID: 7775602
[TBL] [Abstract][Full Text] [Related]
16. Bystander killing of melanoma cells using the human tyrosinase promoter to express the Escherichia coli purine nucleoside phosphorylase gene.
Hughes BW; Wells AH; Bebok Z; Gadi VK; Garver RI; Parker WB; Sorscher EJ
Cancer Res; 1995 Aug; 55(15):3339-45. PubMed ID: 7614469
[TBL] [Abstract][Full Text] [Related]
17. Deletional analysis of the human renin promoter: transcriptional activation by the SV40 enhancer enables identification of promoter regulatory elements in non-renin-expressing cells.
Kasahara N
Bull Tokyo Med Dent Univ; 1993 Jun; 40(2):79-91. PubMed ID: 8390924
[TBL] [Abstract][Full Text] [Related]
18. Effect of pyrroloquinoline quinone (PQQ) on melanogenic protein expression in murine B16 melanoma.
Sato K; Toriyama M
J Dermatol Sci; 2009 Feb; 53(2):140-5. PubMed ID: 19013771
[TBL] [Abstract][Full Text] [Related]
19. Expression of melanin-related genes in cultured adult human retinal pigment epithelium and uveal melanoma cells.
Lu F; Yan D; Zhou X; Hu DN; Qu J
Mol Vis; 2007 Nov; 13():2066-72. PubMed ID: 18079680
[TBL] [Abstract][Full Text] [Related]
20. A novel attenuated replication-competent adenovirus for melanoma therapy.
Peter I; Graf C; Dummer R; Schaffner W; Greber UF; Hemmi S
Gene Ther; 2003 Apr; 10(7):530-9. PubMed ID: 12646858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]